Trial Search Results

Overcoming Barriers and Obstacles to Adopting Diabetes Devices

This study will create a comprehensive, multicomponent behavioral intervention package (ONBOARD; OvercomiNg Barriers & Obstacles to Adopting Diabetes Devices). ONBOARD will provide adults with type 1 diabetes (T1D) the skills to maximize benefit and minimize daily interference from barriers associated with continuous glucose monitoring (CGM) and increase readiness for closed loop.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Molly Tanenbaum

Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Stanford Investigator(s):


  • Behavioral: ONBOARD




Inclusion Criteria:

   1. Subject is age 18-50 years at time of screening

   2. Subject is within first year of continuous glucose monitor use OR has not been using
   CGM regularly in the past 6 months

   3. Subject has a clinical diagnosis of type 1 diabetes

   4. Subject comprehends spoken and written English

Exclusion Criteria:

   1. Subject has a medical disorder that in the judgment of the investigator will interfere
   with completion of any aspect of the protocol.

   2. Subject has a neurologic disorder that in the judgment of the investigator will affect
   completion of the protocol.

Ages Eligible for Study

18 Years - 50 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Molly Tanenbaum, PhD
Not Recruiting